Improve combines a global, secure file repository with a robust and versatile modeling management interface for 3rd party tools like NONMEM®,…
Read moreSoftware Demonstration
Reproducible Reporting
Reproducible Reporting Pharmacometrics in Phase III analyses poses unique challenges such as short time lines, large data bases, multiple end-points,…
Read moreA flexible and transparent MATLAB framework for empirical and mechanistic pharmacometric modelling
Objectives: There exist a number of established software tools for well-defined modelling purposes, like NONMEM or Monolix [1-2] for the…
Read moreSimulo: a new PK-PD-Disease model simulator
What is Simulo? Simulo is a new PK-PD-Disease model simulator, providing a user-friendly interface available on the web. It was…
Read moreData exploration libraries in KIWI
Objectives: Data exploration is critical to the success and efficiency of pharmacometric analyses by allowing the identification of key data…
Read moreOpen source software from the Uppsala University Pharmacometrics group
The Uppsala University pharmacometrics group develops and maintains several different open source software packages. assemblerr – Construction of pharmacometric models…
Read morePerl speaks NONMEM (PsN)
PsN is an open source toolbox for population PK/PD model building using NONMEM. It has broad functionality ranging from results…
Read morePerl speaks NONMEM (PsN)
PsN [1][2][3] is an open source toolbox for population PK/PD model building using NONMEM. It has broad functionality ranging from…
Read moreOpen source software from the Uppsala University Pharmacometrics group
The Uppsala University pharmacometrics group develops and maintains several different open-source software packages. assemblerr – Construction of pharmacometric models by…
Read moreOpen source software from the Uppsala University Pharmacometrics group
The Uppsala University pharmacometrics group develops and maintains several different open source software packages. assemblerr – Construction of pharmacometric models…
Read more